Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MORPHINE Cause Malignant neoplasm progression? 280 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 280 reports of Malignant neoplasm progression have been filed in association with MORPHINE (Morphine Sulfate). This represents 0.2% of all adverse event reports for MORPHINE.

280
Reports of Malignant neoplasm progression with MORPHINE
0.2%
of all MORPHINE reports
112
Deaths
164
Hospitalizations

How Dangerous Is Malignant neoplasm progression From MORPHINE?

Of the 280 reports, 112 (40.0%) resulted in death, 164 (58.6%) required hospitalization, and 15 (5.4%) were considered life-threatening.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MORPHINE. However, 280 reports have been filed with the FAERS database.

What Other Side Effects Does MORPHINE Cause?

Drug dependence (40,036) Overdose (26,942) Pain (22,787) Death (17,960) Emotional distress (17,954) Toxicity to various agents (15,337) Drug withdrawal syndrome (14,954) Drug hypersensitivity (11,095) Drug abuse (6,636) Dependence (5,656)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Which MORPHINE Alternatives Have Lower Malignant neoplasm progression Risk?

MORPHINE vs MORPHINE\NALTREXONE MORPHINE vs MOSAPRIDE MORPHINE vs MOSUNETUZUMAB MORPHINE vs MOSUNETUZUMAB-AXGB MORPHINE vs MOXIFLOXACIN

Related Pages

MORPHINE Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression MORPHINE Demographics